David Keire
David Keire is acting laboratory chief, Branch I, Division of Pharmaceutical Analysis, FDA
Articles
New content coming soon.
Latest Updated Articles
Published: October 11th 2024 | Updated: March 3rd 2025
Exploring New Advancements in ADC Technologies (CPHI Milan 2024)
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: June 2nd 2025 | Updated: June 13th 2025
Inspiring Developments
Published: May 12th 2025 | Updated: June 13th 2025
ASGCT 2025: Emerging Modalities for Cancer Treatments
Published: April 29th 2025 | Updated: June 13th 2025
Mastering SEC Biotherapeutic Characterization and Method Development
